Ability to reverse deeper levels of unintended sedation

Digestion

Volumn 82, Issue 2, 2010, Pages 94-96

  Morse, John ^a   Bamias, Giorgos ^b  

^a Division of Emergency Medicine   (Canada)

^b LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Flumazenil; Naloxone; Reversal agents

Indexed keywords

BENZODIAZEPINE; FENTANYL; FLUMAZENIL; MIDAZOLAM; NALOXONE; NARCOTIC AGENT; OPIATE; PETHIDINE;

CARDIOVASCULAR FUNCTION; CONSCIOUS SEDATION; DEEP SEDATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; GASTROINTESTINAL ENDOSCOPY; HUMAN; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RESPIRATORY FUNCTION; SEDATION; SHORT SURVEY; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; BENZODIAZEPINES; CONSCIOUS SEDATION; DEEP SEDATION; ENDOSCOPY, GASTROINTESTINAL; FLUMAZENIL; HUMANS; NALOXONE;

EID: 77951497491     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000285519     Document Type: Short Survey

References (15)

1. Rex DK: Review article: moderate sedation for endoscopy: sedation regimens for nonanaesthesiologists. Aliment Pharmacol Ther 2006; 24: 163-171.
2. American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non- Anesthesiologists: Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology 2002; 96: 1004-1017.
3. Patel S, Vargo JJ, Khandwala F, Lopez R, Trolli P, Dumot JA, Conwell DL, Zuccaro G: Deep sedation occurs frequently during elective endoscopy with meperidine and midazolam. Am J Gastroenterol 2005; 100: 2689-2695.
4. King KP: Where is the line between deep sedation and general anesthesia? Am J Gastroenterol 2002; 97: 2485-2486.
5. Cohen LB, Delegge MH, Aisenberg J, Brill JV, Inadomi JM, Kochman ML, Piorkowski JD: AGA institute review of endoscopic sedation. Gastroenterology 2007; 133: 675-701.
6. Dahan A, Aarts L, Smith TW: Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology 2010; 112: 226-238.
7. Greenwald B: Narcan use in the endoscopy lab: an important component of patient safety. Gastroenterol Nurs 2004; 27: 20-21.
8. American Society For Gastrointestinal Endoscopy: Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy. Gastrointest Endosc 2003; 58: 317-322.
9. Mora CT, Torjman M, White PF: Sedative and ventilator effects of midazolam infusion: effect of flumazenil reversal. Can J Anaesth 1995; 42: 677-684.
10. Kankaria A, Lewis JH, Ginsberg G, Gallagher J, al-Kawas FH, Nguyen CC, Fleischer DE, Benjamin SB: Flumazenil reversal of psychomotor impairment due to midazolam or diazepam for conscious sedation for upper endoscopy. Gastrointest Endosc 1996; 44: 416-421.
11. Gross JB, Bloouin RT, Zanberg S, Conard P, Jurgen H: Effect of flumazenil on ventilatory drive during sedation with midazolam and alfentanil. Anesthesiology 1996; 85: 713-720.
12. Mintzer MZ, Stoller KB, Griffiths RR: A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users. Psychopharmacology (Berl) 1999; 147: 200-209.
13. Cappell MS: Sedation and analgesia for gastrointestinal endoscopy during pregnancy. Gastrointest Endosc Clin N Am 2006; 16: 1-31.
14. Wehrmann T, Kokabpick S, Lembcke B, Caspary WF, Seifert H: Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study. Gastrointest Endosc 1999; 49: 677-683.
15. Cohen LB, Wecsler JS, Gaetano JN, Benson BA, Miller KM, Durkalski V, Aisenberg J: Endoscopic sedation in the United States: results from a nationwide survey. Am J Gastroenterol 2006; 101: 967-974.